Clinical Trial Update: A Double-Blind, Placebo-Controlled Trial of Paromomycin for Treatment of Cryptosporidiosis in Patients With Advanced HIV Disease and CD4 Counts Under 150 Cells/mm3 [Phase 2]

View source ↗

Summary

Phase 2 double-blind, placebo-controlled trial of paromomycin for treating cryptosporidiosis in advanced HIV patients with CD4 count <150 cells/mm3 has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cryptosporidiosis
• HIV Infections

Drugs mentioned

• Paromomycin (paromomycin)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Cryptosporidiosis, HIV Infections | Phase 2 | Status: COMPLETED